Brief: SMS Pharma Says "Strongly Condemn" News On Divis Labs Buying Co's Stake
16/09/2020 06:24
Sept 16 (Reuters) - Sms Pharmaceuticals Ltd SMSP.NS :
* "STRONGLY CONDEMN" NEWS ON DIVIS LABRATORIES ACQUIRING
STAKE IN
CO
Source text for Eikon: ID:nBSE5YrJjz
Further company coverage: SMSP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SMS Pharmaceuticals
See all newsBrief: SMS Pharmaceuticals Ltd Q2 Consol Net Profit INR 398.5 Million
Brief: SMS Pharmaceuticals March-Quarter Consol Net Profit 327.1 Million Rupees
Brief: Sms Pharmaceuticals Says Tax Demand Reduced To 4 Million Rupees From 71.9 Million Rupees
Advisory: Alert incorrectly tagged to SMS Phramaceuticals withdrawn
Brief: SMS Pharmaceuticals Says Completion Of USFDA Inspection At Vizag Manufacturing Facility